Short-term Outcomes of Aflibercept for Neovascular Age-related Macular Degeneration in Eyes Previously Treated with Other Vascular Endothelial Growth Factor Inhibitors

PURPOSE: To report results of aflibercept therapy in eyes with neovascular age-related macular degeneration previously treated with bevacizumab and/or ranibizumab. DESIGN: Retrospective, interventional, non-comparative, consecutive case series METHODS: Ninety-six eyes, 85 patients, with neovascular...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ho, Vincent Y, Yeh, Steven, Olsen, Timothy W., Bergstrom, Chris S., Yan, Jiong, Cribbs, Blaine E., Hubbard, G. Baker
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4177078/
https://ncbi.nlm.nih.gov/pubmed/23664153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2013.02.009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi